Clinical Trial Update: Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic umbilical cord mesenchymal stromal cells for chronic antibody-mediated rejection in kidney transplantation (not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection

Drugs mentioned

• Allogeneic Umbilical Cord Mesenchymal Stromal Cells (mesenchymal stromal cells)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Chronic Antibody-mediated Rejection (cABMR) | Phase 2 | Status: NOT_YET_RECRUITING